by Harold Pickmans | Nov 18, 2021 | Article
On September 1, 2021, in an appeal from the United States District Court for the Central District of California (“DCCDC”), The United States Court of Appeals for the Federal Circuit (“CAFC”) clarified the standard for damages under 35 U.S.C §287 in a precedential...
by Harold Pickmans | Sep 24, 2021 | Article
In August 2021, the United States Court of Appeals for the Federal Circuit issued a decision in GlaxoSmithKline, LLC, SmithKline Beecham (Cork) Ltd. (“GSK”) v. Teva Pharmaceuticals USA, Inc. (“Teva”) regarding claims Teva infringed on GSK’s Patent. GlaxoSmithKline LLC...
